2020
DOI: 10.3390/pharmaceutics12080695
|View full text |Cite
|
Sign up to set email alerts
|

Polymeric Nanoparticle Associated with Ceftriaxone and Extract of Schinopsis Brasiliensis Engler against Multiresistant Enterobacteria

Abstract: Bacterial resistance has become an important public health problem. Bacteria have been acquiring mechanisms to resist the action of antimicrobial active pharmaceutical ingredients (API). Based on this, a promising alternative is the use of nanotechnology, since when the systems are presented in nanometric size, there is an increase in the interaction and concentration of the action at the target site improving the activity. Thus, this study aims to develop a polymeric nanoparticle (PN) composed of chitosan and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 63 publications
1
7
0
Order By: Relevance
“…The antibacterial activity of these polymeric systems was evaluated against multi-drug-resistant Enterobacteriaceae , namely ESBL-producing (extended-spectrum beta-lactamases) E. coli clinical isolates and carbapenemase-producing K. pneumoniae clinical isolates. The results revealed a considerable improvement in the antibacterial activity, the polymeric systems reaching an improvement of 133 times in the minimum inhibitory activity of ceftriaxone [ 73 ].…”
Section: Pharmacological Potential Of Chitosan and Its Derivatives Applications In Current Pharmacotherapymentioning
confidence: 99%
“…The antibacterial activity of these polymeric systems was evaluated against multi-drug-resistant Enterobacteriaceae , namely ESBL-producing (extended-spectrum beta-lactamases) E. coli clinical isolates and carbapenemase-producing K. pneumoniae clinical isolates. The results revealed a considerable improvement in the antibacterial activity, the polymeric systems reaching an improvement of 133 times in the minimum inhibitory activity of ceftriaxone [ 73 ].…”
Section: Pharmacological Potential Of Chitosan and Its Derivatives Applications In Current Pharmacotherapymentioning
confidence: 99%
“…Another strategy for antibacterial therapies involves developing polymeric nanoparticles as nanocarriers of both antibiotic drugs and alternative biocompounds. For example, de Oliveira et al developed polymeric nanoparticles consisting of chitosan and hydroxypropylmethylcellulose to administer the ceftriaxone antibiotic and S. brasiliensis extract in antibacterial therapies [ 128 ].…”
Section: Antimicrobial Applications Of Polymeric Nanoparticlesmentioning
confidence: 99%
“…Several natural drugs have already been approved for clinical use, namely for antioxidant and antimicrobial purposes [178,179]. Notwithstanding, their combination as organic particles has also been object of several studies, while emphasizing their antioxidant [158,204,205] and antimicrobial capabilities [204,206,207]. If loaded into CS-based nano-or micro-scale organic particles [115], plant extracts hold the power to confer strong and long-lasting effects, without the consequences of overdose-induced tissue damage or inefficiency due to drug biodegradation ahead of reaching the target site.…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%